About
NBE-Therapeutics develops next-generation antibody-drug conjugates (ADCs) targeting solid tumors to create innovative oncology treatments that improve survival and quality of life for cancer patients.
Explore NBE-Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.